{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:45Z","timestamp":1784557065042,"version":"3.55.0"},"reference-count":18,"publisher":"Bioscientifica","license":[{"start":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T00:00:00Z","timestamp":1557964800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["edm.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,5,16]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Diazoxide is the first-line treatment for patients with hyperinsulinaemic hypoglycaemia (HH). Approximately 50% of patients with HH are diazoxide resistant. However, marked diazoxide sensitivity resulting in severe hyperglycaemia is extremely uncommon and not reported previously in the context of HH due to\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation. We report a novel observation of exceptional diazoxide sensitivity in a patient with HH due to\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation. A female infant presented with severe persistent neonatal hypoglycaemia and was diagnosed with HH. Standard doses of diazoxide (5\u2009mg\/kg\/day) resulted in marked hyperglycaemia (maximum blood glucose 21.6\u2009mmol\/L) necessitating discontinuation of diazoxide. Lower dose of diazoxide (1.5\u2009mg\/kg\/day) successfully controlled HH in the proband, which was subsequently confirmed to be due to a novel\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation. At 3 years of age, the patient maintains age appropriate fasting tolerance on low dose diazoxide (1.8\u2009mg\/kg\/day) and has normal development. Diagnosis in proband\u2019s mother and maternal aunt, both of whom carried\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation and had been diagnosed with presumed type 1 and type 2 diabetes mellitus, respectively, was revised to maturity-onset diabetes of young (MODY). Proband\u2019s 5-year-old maternal cousin, also carrier of\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation, had transient neonatal hypoglycaemia. To conclude, patients with HH due to\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation may require lower diazoxide than other group of patients with HH. Educating the families about the risk of marked hyperglycaemia with diazoxide is essential. The clinical phenotype of\n                    <jats:italic>HNF4A<\/jats:italic>\n                    mutation can be extremely variable.\n                  <\/jats:p>\n                  <jats:sec>\n                    <jats:title>Learning points:<\/jats:title>\n                    <jats:list list-type=\"bullet\">\n                      <jats:list-item>\n                        <jats:p>Awareness of risk of severe hyperglycaemia with diazoxide is important and patients\/families should be accordingly educated.<\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          Some patients with HH due to\n                          <jats:italic>HNF4A<\/jats:italic>\n                          mutations may require lower than standard doses of diazoxide.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                      <jats:list-item>\n                        <jats:p>\n                          The clinical phenotype of\n                          <jats:italic>HNF4A<\/jats:italic>\n                          mutation can be extremely variable.\n                        <\/jats:p>\n                      <\/jats:list-item>\n                    <\/jats:list>\n                  <\/jats:sec>","DOI":"10.1530\/edm-19-0013","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T11:33:48Z","timestamp":1558006428000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-2","source":"Crossref","is-referenced-by-count":5,"title":["Exceptional diazoxide sensitivity in hyperinsulinaemic hypoglycaemia due to a novel HNF4A mutation"],"prefix":"10.1530","volume":"2019","author":[{"given":"Ved Bhushan","family":"Arya","sequence":"first","affiliation":[{"name":"1Department of Paediatric Endocrinology, Variety Club Children\u2019s Hospital, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kalitsi","sequence":"additional","affiliation":[{"name":"1Department of Paediatric Endocrinology, Variety Club Children\u2019s Hospital, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Hickey","sequence":"additional","affiliation":[{"name":"2Department of Neonatology, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Flanagan","sequence":"additional","affiliation":[{"name":"3Institute of Biomedical and Clinical Science, University of Exeter, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritika R","family":"Kapoor","sequence":"additional","affiliation":[{"name":"1Department of Paediatric Endocrinology, Variety Club Children\u2019s Hospital, King\u2019s College Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref111","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db07-1657","article-title":"Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4. A mutations","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/jpem-2018-0112","article-title":"Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis","volume":"31","year":"2018","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"200082","DOI":"10.1136\/fn.82.2.F98","article-title":"Practical management of hyperinsulinism in of Disease in : and https org","author":"Aynsley","journal-title":"infancy Archives Childhood Fetal Neonatal Edition"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","article-title":"Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene","volume":"4","year":"2007","journal-title":"PLoS Medicine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1530\/EJE-09-0861","article-title":"Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations","volume":"162","year":"2010","journal-title":"European Journal of Endocrinology"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000446396","article-title":"Hepatocyte nuclear factor-4 Alfa mutation associated with hyperinsulinaemic hypoglycaemia and atypical renal Fanconi syndrome: expanding the clinical phenotype","volume":"86","year":"2016","journal-title":"Hormone Research in Paediatrics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0034-1367063","article-title":"Hyperinsulinaemic hypoglycaemia","volume":"46","year":"2014","journal-title":"Hormone and Metabolic Research"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3476(71)80241-X","article-title":"Hyperosmolar nonketotic coma associated with diazoxide therapy for hypoglycemia","volume":"78","year":"1971","journal-title":"Journal of Pediatrics"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.2337\/db07-1657","article-title":"Persistent hyperinsulinemic hypoglycemia and maturity-onset diabetes of the young due to heterozygous HNF4. A mutations","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0034-1367063","article-title":"Hyperinsulinaemic hypoglycaemia","volume":"46","year":"2014","journal-title":"Hormone and Metabolic Research"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/adc.2008.148171","article-title":"Hyperinsulinaemic hypoglycaemia","volume":"94","year":"2009","journal-title":"Archives of Disease in Childhood"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1515\/jpem-2018-0112","article-title":"Diazoxide toxicity in a child with persistent hyperinsulinemic hypoglycemia of infancy: mixed hyperglycemic hyperosmolar coma and ketoacidosis","volume":"31","year":"2018","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1159\/000446396","article-title":"Hepatocyte nuclear factor-4 Alfa mutation associated with hyperinsulinaemic hypoglycaemia and atypical renal Fanconi syndrome: expanding the clinical phenotype","volume":"86","year":"2016","journal-title":"Hormone Research in Paediatrics"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1371\/journal.pmed.0040118","article-title":"Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene","volume":"4","year":"2007","journal-title":"PLoS Medicine"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/adc.2008.148171","article-title":"Hyperinsulinaemic hypoglycaemia","volume":"94","year":"2009","journal-title":"Archives of Disease in Childhood"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0022-3476(71)80241-X","article-title":"Hyperosmolar nonketotic coma associated with diazoxide therapy for hypoglycemia","volume":"78","year":"1971","journal-title":"Journal of Pediatrics"},{"key":"ref01","doi-asserted-by":"publisher","first-page":"200082","DOI":"10.1136\/fn.82.2.F98","article-title":"Practical management of hyperinsulinism in of Disease in : and https org","author":"Aynsley","journal-title":"infancy Archives Childhood Fetal Neonatal Edition"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1530\/EJE-09-0861","article-title":"Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations","volume":"162","year":"2010","journal-title":"European Journal of Endocrinology"}],"container-title":["Endocrinology, Diabetes &amp; Metabolism Case Reports"],"original-title":[],"link":[{"URL":"https:\/\/edm.bioscientifica.com\/view\/journals\/edm\/2019\/1\/EDM19-0013.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/edm.bioscientifica.com\/downloadpdf\/journals\/edm\/2019\/1\/EDM19-0013.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:03Z","timestamp":1784555223000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/edm\/article\/35373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,16]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1530\/edm-19-0013","relation":{},"ISSN":["2052-0573"],"issn-type":[{"value":"2052-0573","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,16]]}}}